Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer's disease

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8f18a73fd989967f-LAX IP: 116.62.10.13 UTC time: 2024-12-13T20:20:10+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4